Table 27.1 Causes of chest pain. a The increase in LVEDP reduces the pressure gradient between aortic diastolic pressure and LVEDP, i.e., the coronary perfusing pressure in diastole, and thus reduces coronary flow even in the absence of CAD. Also, elevated LVEDP increases microvascular resistance. Three clinical features point to the possibility of aortic dissection:3 The presence of two or three features makes aortic dissection highly probable. The probability is intermediate when one feature is present; aortic imaging is warranted in the latter case if symptoms are not clearly explained by chest X-ray (CXR) or ECG. Up to 5% of aortic dissections have none of the features but may be suspected by a widened mediastinum on CXR. In addition to the classic hypertension, hypotension may be seen with complicated aortic dissection (AI, tamponade). Hypotension may also be a pseudohypotension resulting from the obstruction of flow to one limb. Measuring blood pressure in all limbs may unveil this phenomenon. (80–90 bpm). The probability is high when two or three features are present, intermediate when only one feature is present, and low when none is present. Pericarditis is characterized by pleuritic chest pain that increases with recumbency and movements and improves with leaning forward. It typically radiates to the trapezius. It has a rapid onset. (1) chest pain; (2) rub; (3) typical ECG findings (widespread ST-segment elevation and/or PR depression); (4) pericardial effusion (which is only present in 40% of pericarditis cases and usually small). CRP is a confirmatory fifth finding. Pleural and pulmonary illnesses are characterized by dyspnea, cough, and pleuritic chest pain, i.e., sharp pain that increases with deep inspiration, cough, or movement. See Chapter 3, Section II and Figures 3.1 and 3.2. If the ECG shows ST elevation consistent with STEMI, perform emergent reperfusion with primary PCI or fibrinolysis. If the ECG shows ST depression or deep T inversion consistent with ischemia, especially if dynamic, consider the diagnosis of non-ST elevation ACS, but keep in mind the possibility of aortic dissection, PE, or pericarditis if clinically plausible. In ACS, a bedside echo performed during active chest pain typically reveals a wall motion abnormality. In fact, a normal echo during active chest pain reduces the likelihood of ACS. Echo is less sensitive if performed after pain resolution. Conversely, echo is not very specific for ACS, as a wall motion abnormality may correspond to an old infarct. Strain echocardiography (global or regional) improves the sensitivity and negative predictive value of echo for ACS diagnosis in patients with normal initial troponin and non-diagnostic ECG (91%) but is non-specific and has a poor positive predictive value (13% in one study).4 If aortic dissection is suggested, perform aortic CT or emergent TEE and start aggressive BP control and intravenous β-blockers. If PE is suggested (clinical probability high, or intermediate with + D-dimer), perform chest CT angiography, PE protocol. The same CT and contrast injection are usually appropriate for the diagnosis of aortic dissection as well (but not vice versa). V/Q scan may be performed instead of CT in renal failure with no severe CXR abnormalities; CXR abnormalities decrease the specificity and the diagnostic yield of the V/Q scan. Anticoagulation is started early on, before the workup, if PE is probable and the bleeding risk is low. If pericarditis is suggested, the diagnosis will be established by clinical, ECG, and CRP features. If a pulmonary cause is suggested, the diagnosis will be established by CXR and chest CT if needed. If cholecystitis or acute pancreatitis is suggested, the diagnosis will be established by a liver function panel, amylase/lipase and abdominal ultrasound. ESC and multiple European investigators suggest checking hs-troponin at presentation and at 1 or 2 hours after presentation (0/1 or 0/2 strategy). An undetectable hs-troponin, or a detectable hs-troponin with insignificant change at 1 or 2 hours rules out MI with >99.5% confidence (Figure 27.1).5–14 Most patients who rule out have non-cardiac chest pain, particularly if ruled out with the hs-troponin strategy. Non-invasive testing with CTA or stress testing may be performed after the second negative troponin; it is not definitely required in patients who rule out with the hs-troponin strategy. Yet some of the latter patients have true angina, especially those with exertional chest pain. CTA or stress testing remains necessary in patients with exertional chest pain: a normal or low-risk stress test result suggests no CAD, microvascular disease, or low-risk CAD for which medical therapy is appropriate. Medical therapy is tailored to how much the physician believes the chest pain is anginal based on clinical grounds and is somewhat comparable to the management of chronic CAD; as such, coronary angiography is performed in those patients with significant angina on mild exertion. In patients with elevated troponin, the most important step is to distinguish type 1 MI from secondary myocardial injury, by clinical context. Up to 50% of patients with mild troponin rise (<0.25 ng/ml) have type 2 MI or injury, rather than type 1 MI.5 ST depression on ECG or more severe troponin elevation (>0.5–1) increases the likelihood of CAD and type 1 MI. Notes: Beside HF, there are two additional causes of nocturnal dyspnea:15 In HF, paroxysmal nocturnal dyspnea (PND) usually develops 2–4 hours after sleep and improves after 15–30 minutes of sitting upright or walking. Dyspnea is often accompanied by cough (dry or productive of frothy sputum), wheezing, and diaphoresis. Table 27.2 Causes of acute dyspnea. Diagnosis: history (orthopnea, paroxysmal nocturnal dyspnea, recent quick weight gain, and past cardiac history), exam (↑ JVP, S3, ± S4, crackles, peripheral edema), elevated BNP, chest X-ray Orthopnea is mainly seen in HF but may also be seen with pericardial diseases, advanced asthma/COPD with diaphragmatic flattening and weakness, bilateral diaphragmatic paralysis, severe obesity and severe ascites, all cases where the diaphragm tends be pushed up in a supine position. Platypnea is dyspnea that worsens in the upright position. Platypnea is seen with pulmonary right-to-left shunts such as pulmonary AV fistulas (including hepatopulmonary syndrome), or the rare case of PFO that allows right-to-left shunting in the upright position. Trepopnea is orthopnea that mainly occurs in one lateral decubitus position. Patients with HF are typically more comfortable in the right lateral decubitus position, as this position raises the level of the heart (especially the left ventricle), which slows venous return. This position may partly explain the predominance of right pleural effusion in HF.16 Patients with unilateral lung disease are most comfortable lying over the side of the healthy lung, to improve its perfusion and the V/Q matching. Note that nocturnal or exertional cough, rather than dyspnea, may be the primary complaint of patients with HF, and patients with cough-variant asthma. Any shock leads to tachypnea (the patient hyperventilates in order to improve O2 supply). Think specifically of: Wheezing may indicate COPD/asthma but may also indicate pulmonary edema (“cardiac asthma”), PE, or pneumonia. In cardiac asthma, cyanosis and diaphoresis occur more often than in bronchial asthma, and adventitious breath sounds are more common (crackles, rhonchi). True asthma has more musical, pure wheezes.15 Most of the disorders listed in Table 27.2, A–C, lead to a pulmonary shunt effect in which pulmonary blood is not oxygenated because of obstruction of the airways, or to a true pulmonary shunt in which the alveoli, per se, are obstructed and filled with fluid. A pulmonary shunt or shunt effect initially leads to hypocapnia, hypoxemia, or normoxemia (pO2 may be normal early on), and elevated A–a gradient. A–a gradient increases in most pulmonary pathologies; it implies V/Q mismatch but does not identify it. The more severe the process, the higher the A–a gradient rises.
27
Chest Pain, Dyspnea, Palpitations
1. CHEST PAIN
I. Causes (see Table 27.1)
II. Features
A. Angina and acute coronary syndrome
B. Aortic dissection
C. Pulmonary embolism (PE)
1. Clinical features
2. The clinical probability of PE is assessed using the Wells criteria, which essentially give weight to three features
3. Initial workup
D. Acute pericarditis
E. Pneumonia, pleural effusion, pneumothorax
III. Management of chronic chest pain
IV. Management of acute chest pain
A. ECG
B. CXR, cardiac troponin (sensitive or highly sensitive assay), ± bedside echo during active pain
C. If any clinical, X-ray, or ECG feature suggests aortic dissection, PE, pericarditis, or a pulmonary cause of chest pain, proceed to the appropriate workup and therapy. Avoid anticoagulation if the clinical or radiographic likelihood of aortic dissection is more than low. Before starting anticoagulation, verify the lack of mediastinal enlargement on CXR.
D. In the absence of aortic dissection, PE, pericarditis, or pulmonary features, use conventional troponin or hs-troponin for MI rule-in and rule-out. A single undetectable or very low hs-troponin (eg, <0.005 ng/ml) is associated with <0.5% risk of acute MI and nearly 0% risk of cardiac death at 30 days. This risk is further reduced in patients whose ECG is not suggestive of ischemia. Therefore, home discharge is safe in those patients.
2. ACUTE DYSPNEA
I. Causes (see Table 27.2)
Diagnosed by the following three features: (i) PE/DVT risk factors; (ii) DVT signs; and (iii) absence of other causes of dyspnea (no gross abnormalities on chest X-ray)
+Laryngeal causes (laryngospasm, laryngeal edema [anaphylaxis]) lead to an inspiratory stridor ± urticaria
+Metabolic causes: Metabolic acidosis (such as diabetic ketoacidosis), hypocalcemia, dyskalemia, severe acute anemia, hyperthyroid storm
II. Notes
A. Differential diagnosis of shock + respiratory distress
B. Wheezing
C. Pulmonary shunt and pulmonary shunt effect